The Brain Research Institute at Niigata University has developed a breakthrough technique for early glioma diagnosis using droplet digital PCR technology. This innovation detects H3K27M-mutant droplets in circulating tumor DNA from cerebral spinal fluid, enabling earlier identification of leptomeningeal disease. The technique